Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches
Baxter exits China IV fluids market amid tough local competition, US shortage
Big Pharma earnings hang hope on the next generation of blockbusters
Novo takes big step toward ending Ozempic, Wegovy shortages
*please scroll down for all the latest news*
